Latest filings (excl ownership)
15-12B
Securities registration termination
30 Jul 21
25-NSE
Exchange delisting
29 Jul 21
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
20 Jul 21
8-K
China Jo-Jo Drugstores Reports Fiscal Year 2021 Financial Results
1 Jul 21
10-K
2021 FY
Annual report
29 Jun 21
DEF 14A
Definitive proxy
2 Jun 21
8-K
Entry into a Material Definitive Agreement
14 May 21
8-K
Amendments to Articles of Incorporation or Bylaws
22 Apr 21
8-K
China Jo-Jo Drugstores Reports Third Quarter Fiscal 2021 Financial Results
12 Feb 21
10-Q
2021 Q3
Quarterly report
12 Feb 21
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Dec 20
S-8
Registration of securities for employees
24 Nov 20
10-Q
2020 Q2
Quarterly report
13 Nov 20
8-K
China Jo-Jo Drugstores Reports Second Quarter 2021 Financial Results
13 Nov 20
8-K
Submission of Matters to a Vote of Security Holders
29 Oct 20
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Oct 20
DEF 14A
Definitive proxy
14 Sep 20
EFFECT
Notice of effectiveness
25 Aug 20
CORRESP
Correspondence with SEC
19 Aug 20
10-Q
2020 Q1
Quarterly report
14 Aug 20
8-K
China Jo-Jo Drugstores Reports First Quarter 2021 Financial Results
14 Aug 20
UPLOAD
Letter from SEC
20 Jul 20
S-1
IPO registration
14 Jul 20
10-K
2020 FY
Annual report
10 Jul 20
8-K
China Jo-Jo Drugstores Reports Fiscal Year 2020 Financial Results
10 Jul 20
8-K
Other Events
26 Jun 20
D
$9.75M in options / securities to be acquired, sold $9.75M, 3 investors
16 Jun 20
8-K
Departure of Directors or Certain Officers
15 Jun 20
8-K
China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering
3 Jun 20
424B5
Prospectus supplement for primary offering
2 Jun 20
8-K
China Jo-Jo Drugstores Announces $10 Million Registered Direct Offering
2 Jun 20
8-K
Submission of Matters to a Vote of Security Holders
9 Mar 20
8-K
China Jo-Jo Drugstores Reports Third Quarter 2020 Financial Results
14 Feb 20
10-Q
2020 Q3
Quarterly report
14 Feb 20
DEF 14A
Definitive proxy
21 Jan 20
10-Q
2020 Q2
Quarterly report
14 Nov 19
8-K
China Jo-Jo Drugstores Reports Second Quarter 2020 Financial Results
14 Nov 19
10-Q
2020 Q1
Quarterly report
14 Aug 19
8-K
China Jo-Jo Drugstores Reports First Quarter 2020 Financial Results
14 Aug 19
Latest ownership filings
SC 13G/A
China Jo-jo Drugstores, Inc.
8 Jan 20
SC 13G
China Jo-jo Drugstores, Inc.
10 May 19
SC 13G/A
China Jo-jo Drugstores, Inc.
15 Mar 19
3
Wei Hu
29 Nov 18
3
Pingfan Wu
29 Nov 18
3
Liu Yan
29 Nov 18
3
Jiangliang He
29 Nov 18
3
Caroline Wang
29 Nov 18
4
Lei Liu
3 Jul 18
4
Lei Liu
12 Apr 18
4
Ming Zhao
12 Apr 18
SC 13G
China Jo-jo Drugstores, Inc.
15 Feb 17
3
Initial statement of insider ownership
30 Jan 17
SC 13D
China Jo-jo Drugstores, Inc.
30 Jan 17
4
Lei Liu
31 Oct 16
SC 13G/A
China Jo-jo Drugstores, Inc.
14 Jan 16
4
Zhimin Su
1 Dec 15
4
LI LEI
1 Dec 15
4
Li Qi
1 Dec 15
4
Genghua Gu
1 Dec 15
4
Ming Zhao
1 Dec 15
SC 13G
China Jo-jo Drugstores, Inc.
7 Aug 15
SC 13D
China Jo-jo Drugstores, Inc.
15 Jul 14
SC 13G
China Jo-jo Drugstores, Inc.
15 Jul 14